PBC Research
The Canadian PBC Society worked with Dr. Puneeta Tandon and her team at the University of Alberta on the Empower Wellness Program. After completing a
August 21, 2026
No Comments
Blog
Author: Gail Wright
- Home
- Author: Gail Wright
PBC News
Gilead Science Inc announced that Health Canada has approved LYVDELZI® (seladelpar) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA)
October 23, 2025
No Comments
April 28, 2025 – Ipsen Biopharmaceuticals Canada Inc. today announced Health Canada has issued a Notice of Compliance with Conditions (NOC/c) approving IQIRVO® (elafibranor) for the
April 30, 2025
No Comments
FOR RELEASE ON JULY 5, 2024 7:00 AM EST – NEW YORK / TORONTO PBCers and Canadian PBC Society Press Release for PBC Patients: Important
July 5, 2024
No Comments
PBC Blog
Hi everyone, my name is Maria. I live in Brampton, Ontario, am 53 years old, married for almost 18 years and have a 14 year
August 16, 2023
No Comments
Clinical Trials
The 52-week IDEAL study aims to enroll 75 patients with PBC who have an incomplete response or intolerance to ursodeoxycholic acid (UDCA), in each case
August 14, 2023
No Comments
PBC Blog
Growing up, we had a Pressure Cooker. It was used frequently and came with specifics instructions. It can hold a great capacity. It needs monitoring,
July 24, 2023
No Comments
Clinical Trials
Ipsen and GENFIT announce positive topline data from the pivotal ELATIVE Phase III trial. In the trial the efficacy and safety of elafibranor, an investigational
June 30, 2023
No Comments
Clinical Trials
Intercept Pharmaceuticals announces new data showing potential of Fixed-Dose Combination of OCA and Bezafibrate to normalize multiple biomarkers in PBC to be featured in podium
June 11, 2023
No Comments
PBC Blog
My name is Susan and I was diagnosed with PBC in 1992 at the age of 38. There were no support groups at that time
June 5, 2023
No Comments